Piflufolastat F 18 Not Yet Recruiting Phase 4 Trials for Metastatic Castration-resistant Prostate Carcinoma / Prostate Cancer / Metastatic Castration-Resistant Prostate Cancer (mCRPC) Diagnostic

IndicationsStatusPurposePhase
Not Yet RecruitingDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT06099093Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan